As filed with the Securities and Exchange Commission on February 28, 2024
Registration No. 333- 274558
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON DC 20549
POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
Ampio Pharmaceuticals, Inc. |
(Exact name of registrant as specified in its charter) |
|
Delaware | | 26-0179592 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
| | |
9800 Mount Pyramid Court, Suite 400 Englewood, Colorado 80112 (720) 437-6500 |
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) |
| | |
Michael A. Martino Chief Executive Officer Ampio Pharmaceuticals, Inc. 9800 Mount Pyramid Court, Suite 400 Englewood, Colorado 80112 (720) 437-6500 (Address, including zip code, and telephone number including area code, of agent for service) | | Copies to: April Hamlin, Esq. Ballard Spahr LLP 2000 IDS Center 80 South 8th Street Minneapolis, MN 55402 (612) 371-3211 |
| | |
Approximate date of commencement of proposed sale to the public: This post-effective amendment is being filed to deregister the unsold securities previously registered under this Registration Statement.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective on filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐